ADMA Inventory vs Non Current Assets Total Analysis

ADMA Stock  USD 18.67  0.96  4.89%   
ADMA Biologics financial indicator trend analysis is way more than just evaluating ADMA Biologics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ADMA Biologics is a good investment. Please check the relationship between ADMA Biologics Inventory and its Non Current Assets Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.

Inventory vs Non Current Assets Total

Inventory vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ADMA Biologics Inventory account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between ADMA Biologics' Inventory and Non Current Assets Total is 0.9. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of ADMA Biologics, assuming nothing else is changed. The correlation between historical values of ADMA Biologics' Inventory and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of ADMA Biologics are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Inventory i.e., ADMA Biologics' Inventory and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.9
Relationship DirectionPositive 
Relationship StrengthVery Strong

Inventory

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from ADMA Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ADMA Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.At present, ADMA Biologics' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 226.09, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
 2021 2022 2023 2024 (projected)
Cost Of Revenue79.8M118.8M169.3M177.7M
Research Development3.6M3.6M3.3M4.4M

ADMA Biologics fundamental ratios Correlations

0.980.950.910.810.980.991.00.90.980.8-0.110.980.99-0.09-0.980.980.980.960.30.930.980.850.960.540.16
0.980.940.950.790.960.990.980.880.940.78-0.120.990.98-0.1-0.980.980.980.950.30.880.970.860.950.560.19
0.950.940.920.650.990.960.960.980.920.650.010.930.950.04-0.930.910.940.870.050.920.980.720.950.50.04
0.910.950.920.580.930.950.910.880.840.57-0.130.940.93-0.1-0.940.90.940.880.150.860.940.720.930.520.11
0.810.790.650.580.690.780.790.570.821.0-0.090.80.78-0.08-0.780.820.750.810.560.630.730.950.660.470.31
0.980.960.990.930.690.970.980.960.950.69-0.090.950.97-0.06-0.950.940.950.90.120.930.990.770.960.480.05
0.990.990.960.950.780.970.980.890.940.77-0.121.00.99-0.09-0.990.980.990.960.30.890.970.840.970.580.15
1.00.980.960.910.790.980.980.920.980.79-0.10.970.99-0.07-0.970.960.970.930.220.930.990.840.940.50.15
0.90.880.980.880.570.960.890.920.880.570.130.860.880.16-0.860.830.860.78-0.10.880.950.650.90.42-0.04
0.980.940.920.840.820.950.940.980.880.81-0.090.930.97-0.07-0.940.950.940.920.270.940.970.840.910.470.16
0.80.780.650.571.00.690.770.790.570.81-0.110.790.78-0.11-0.780.80.740.790.540.620.720.940.650.480.3
-0.11-0.120.01-0.13-0.09-0.09-0.12-0.10.13-0.09-0.11-0.13-0.171.00.19-0.14-0.17-0.15-0.33-0.16-0.08-0.11-0.12-0.01-0.06
0.980.990.930.940.80.951.00.970.860.930.79-0.130.98-0.11-0.980.990.980.970.360.870.960.860.960.590.18
0.990.980.950.930.780.970.990.990.880.970.78-0.170.98-0.14-1.00.980.990.960.310.930.980.830.960.550.18
-0.09-0.10.04-0.1-0.08-0.06-0.09-0.070.16-0.07-0.111.0-0.11-0.140.17-0.12-0.14-0.13-0.34-0.13-0.05-0.1-0.090.0-0.07
-0.98-0.98-0.93-0.94-0.78-0.95-0.99-0.97-0.86-0.94-0.780.19-0.98-1.00.17-0.98-0.99-0.96-0.34-0.91-0.96-0.84-0.95-0.56-0.19
0.980.980.910.90.820.940.980.960.830.950.8-0.140.990.98-0.12-0.980.980.990.440.890.940.860.950.610.19
0.980.980.940.940.750.950.990.970.860.940.74-0.170.980.99-0.14-0.990.980.960.320.920.960.80.970.580.21
0.960.950.870.880.810.90.960.930.780.920.79-0.150.970.96-0.13-0.960.990.960.520.860.90.840.940.640.19
0.30.30.050.150.560.120.30.22-0.10.270.54-0.330.360.31-0.34-0.340.440.320.520.140.140.510.250.450.42
0.930.880.920.860.630.930.890.930.880.940.62-0.160.870.93-0.13-0.910.890.920.860.140.940.660.920.440.12
0.980.970.980.940.730.990.970.990.950.970.72-0.080.960.98-0.05-0.960.940.960.90.140.940.80.950.470.1
0.850.860.720.720.950.770.840.840.650.840.94-0.110.860.83-0.1-0.840.860.80.840.510.660.80.720.460.34
0.960.950.950.930.660.960.970.940.90.910.65-0.120.960.96-0.09-0.950.950.970.940.250.920.950.720.570.14
0.540.560.50.520.470.480.580.50.420.470.48-0.010.590.550.0-0.560.610.580.640.450.440.470.460.570.03
0.160.190.040.110.310.050.150.15-0.040.160.3-0.060.180.18-0.07-0.190.190.210.190.420.120.10.340.140.03
Click cells to compare fundamentals

ADMA Biologics Account Relationship Matchups

ADMA Biologics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets127.1M207.7M276.3M348.5M329.2M345.6M
Short Long Term Debt Total84.7M97.7M102.9M154.4M141.4M148.5M
Total Current Liabilities14.0M19.9M30.4M39.3M49.8M52.3M
Net Debt58.0M41.7M51.8M67.9M90.1M94.6M
Cash26.8M55.9M51.1M86.5M51.4M27.8M
Common Stock Shares Outstanding54.3M86.1M139.6M197.9M224.0M235.2M
Liabilities And Stockholders Equity127.1M207.7M276.3M348.5M329.2M345.6M
Total Liab100.9M119.4M135.1M196.5M194.0M203.7M
Total Current Assets85.8M153.7M208.7M270.4M257.0M269.9M
Other Current Liab4.5M8.0M17.2M25.1M32.9M34.6M
Total Stockholder Equity26.2M88.2M141.2M152.0M135.2M142.0M
Cash And Short Term Investments26.8M55.9M51.1M86.5M51.4M29.7M
Common Stock Total Equity5.9K10.5K19.6K22.2K20.0K19.0K
Non Current Liabilities Total86.9M99.5M104.7M157.2M144.2M151.4M
Other Stockholder Equity290.9M428.7M553.3M630.0M641.4M673.5M
Common Stock5.9K10.5K19.6K22.2K23K29.8K
Retained Earnings(264.7M)(340.5M)(412.1M)(478.0M)(506.3M)(480.9M)
Property Plant And Equipment Net31.7M45.9M58.2M68.7M63.5M66.6M
Accounts Payable9.2M11.1M12.4M13.2M15.7M16.4M
Non Current Assets Total41.3M53.9M67.5M78.1M72.2M75.8M
Other Assets2.8M6.4M4.1M4.8M1.00.95
Net Receivables3.5M13.2M28.6M15.5M27.4M28.8M
Inventory53.1M81.5M124.7M163.3M172.9M181.6M
Other Current Assets2.5M6.1M4.3M10.2M5.3M2.8M
Property Plant And Equipment Gross31.7M45.9M50.9M58.3M90.2M94.7M
Non Currrent Assets Other2.8M2.1M4.1M4.8M4.7M4.9M
Other Liab2.4M2.2B2.4M3.7M4.2M4.0M
Net Tangible Assets19.5M82.3B141.2M152.0M174.8M166.0M
Long Term Debt68.3M93.0M94.9M142.8M130.6M137.1M
Retained Earnings Total Equity(264.7M)(340.5M)(412.1M)(478.0M)(430.2M)(408.7M)
Capital Surpluse290.9M428.7M553.3M630.0M724.5M760.7M
Capital Lease Obligations1.3M4.7M8.1M11.6M10.8M11.4M
Non Current Liabilities Other15.0M54.9K397.4K1.9M2.1M2.0M
Short Term Debt229.1K731.4K591.1K905K863.0K1.2M
Intangible Assets3.2M2.4M1.7M1.0M499K474.1K
Property Plant Equipment31.7M45.9B50.9M58.3M67.0M63.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.27
Revenue Per Share
1.661
Quarterly Revenue Growth
0.781
Return On Assets
0.1989
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.